NCT00400764 2011-11-23A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's LymphomasGenentech, Inc.Phase 1/2 Terminated72 enrolled 20 charts